NCT03460782 2019-11-08An Expanded Access Program of Ipilimumab for Patients With Glioblastomas and GliomasCenter Trials & TreatmentNo longer available
NCT03311542 2018-01-10Expanded Access for Pembrolizumab (MK-3475)Center Trials & TreatmentNo longer available